Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 23, 1993 - Issue 11
62
Views
16
CrossRef citations to date
0
Altmetric
Research Article

Analysis of imipramine and three metabolites produced by isozyme CYP2D6 expressed in a human cell line

, &
Pages 1289-1298 | Received 25 Jan 1993, Accepted 15 Jun 1993, Published online: 22 Sep 2008

References

  • Bahr C., Von Guengerich F. P., Movin G., Nordin C. The use of human liver banks in pharmacogenetic research. Clinical Pharmacology in Psychiatry 1989; 7: 163–171
  • Birgersson C., Morgan E. T., Jörnvall H., Von Bahr C. Purification of a desmethylimipramine and debrisoquine hydroxylating cytochrome P-450 from human liver. Biochemical Pharmacology 1986; 35: 3165–3166
  • Brosen K., Zeugin T., Meyer U. A. Role of P450IID6, the target of the sparteine-debrisoquin oxidation polymorphism, in the metabolism of imipramine. Clinical Pharmacology and Therapeutics 1991; 49: 609–617
  • Coutts R. T., Su P., Baker G. B., Daneshtalab M. Metabolism of imipramine in vitro by isozyme CYP2D6 expressed in a human cell line, and observations on metabolite stability. Journal of Chromatography 1993; 615: 265–272
  • Crammer J. L., Scott B., Rolfe B. Metabolism of 14C-imipramine: II. Urinary metabolites in man. Psychopharmacologia 1969; 15: 207–225
  • Eichelbaum M., Gross A. S. The genetic polymorphism of debrisoquine/sparteine metabolism—clinical aspects. Pharmacology and Therapeutics 1990; 46: 377–394
  • Gentest. Human cytochrome P450 products, cell lines and microsomes. Gentest Corporation Catalog. Woburn, MA 1992; 1991/2
  • Gonzalez F. J. Molecular genetics of the P-450 superfamily. Pharmacology and Therapeutics 1990; 45: 1–38
  • Guengerich F. P., Distlerath L. M., Reilly P. E. B., Wolff T., Shimada T., Umbenhauer D. R., Martin M. V. Human-liver cytochromes P-450 involved in polymorphisms of drug oxidation. Xenobiotica 1986; 16: 367–378
  • Krüger R., Hölzl G., Kuss H. J., Schefold L. Comparison of the metabolism of the three antidepressants, amitriptyline, imipramine, and chlorimipramine in vitro in rat liver microsomes. Psychopharmacology 1986; 88: 505–513
  • Meyer U. A., Kronbach J., Gut T., Skoda C., Meier C., Catin U. T., Dayer P. The molecular mechanisms of two common polymorphisms of drug oxidation—evidence for functional changes in cytochrome P-450 isozymes catalysing bufuralol and mephenytoin oxidation. Xenobiotica 1986; 16: 449–464
  • Nebert D. W., Nelson D. R., Adesnik M., Coon M. J., Estabrook R. W., Gonzalez F. J., Guengerich F. P., Gunsalus I. C., Johnson E. F., Kemper B., Levin W., Philips I. R., Sato R., Waterman M. R. The P450 superfamily: updated listing of all genes and recommended nomenclature for the chromosomal loci. DNA 1989; 8: 1–13
  • Potter W. Z., Calh H. M. Metabolites of tricyclic antidepressants: biological activity and clinical implications. Clinical Pharmacology in Psychiatry, E. Usdin. Elsevier, New York 1981; 311–324
  • Sutfin T. A., Devane C. L., Jusko W. J. The analysis and disposition of imipramine and its active metabolites in man. Psychopharmacology 1984; 82: 310–317
  • Weder H. J., Bickel M. H. Separation and determination of imipramine and its metabolites from biological samples by gas-liquid chromatography. Journal of Chromatography 1968; 37: 181–189
  • Zeugin T. B., Brosen K., Meyer U. A. Determination of imipramine and seven of its metabolites in human liver microsomes by a high-performance liquid chromatographic method. Analytical Biochemistry 1990; 189: 99–102

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.